Key facts
- This page summarizes Jeffrey Blizard's Form 4 filing for SANUWAVE Health, Inc. (SNWV).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2025, 16:38.
Jeffrey Blizard - 22 Oct 2024 Form 4 Insider Report for SANUWAVE Health, Inc. (SNWV)
- Reporting relationship
- Director
- Issuer ticker
- SNWV
- Reported as of
- 22 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2025, 16:38:20 UTC
- Prior SEC filing
- 06 Jun 2024
- Next SEC filing
- 07 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Griffin D. Foster as Attorney-in-Fact for Jeffrey Blizard
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Jeffrey Blizard filed Form 4 for SANUWAVE Health, Inc. (SNWV) on 18 Mar 2025.
Change
- Previous filing in this sequence was filed on 06 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SNWV
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +41,333
- Change %
- Price
- $0.000000
- Shares after
- 41,333
- Date
- 22 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 41,333
- Exercise price
- $14.20
- Footnotes
- F1
SNWV
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +1,559
- Change %
- Price
- $0.000000
- Shares after
- 1,559
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,559
- Exercise price
- $22.76
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant.
Footnote F2
Options were fully vested at the grant date.